Amedeo's Top 20

Amedeo Smart

Independent Medical Education

05 August 2019

Multidisciplinary Journal Club

  1. Ross JDC, Brittain C, Cole M, Dewsnap C, et al.
    Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Lancet 2019.

  1. Venter WDF, Moorhouse M, Sokhela S, Fairlie L, et al.
    Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
    N Engl J Med 2019.

  2. Chen N, Hao C, Liu BC, Lin H, et al.
    Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
    N Engl J Med 2019.

  3. .
    Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1.
    N Engl J Med 2019.

  4. Chen N, Hao C, Peng X, Lin H, et al.
    Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
    N Engl J Med 2019.

  1. Taylor WRJ, Thriemer K, von Seidlein L, Yuentrakul P, et al.
    Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
    Lancet 2019.

  2. Zash R, Holmes L, Diseko M, Jacobson DL, et al.
    Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana.
    N Engl J Med 2019.

  3. Owens DK, Davidson KW, Krist AH, Barry MJ, et al.
    Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement.
    JAMA 2019;322:349-354.

  4. Izzy M, VanWagner LB, Lin G, Altieri M, et al.
    Redefining Cirrhotic Cardiomyopathy For The Modern Era.
    Hepatology 2019.

  5. Bachy E, Seymour JF, Feugier P, Offner F, et al.
    Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study.
    J Clin Oncol 2019.

  1. Johnston KC, Bruno A, Pauls Q, Hall CE, et al.
    Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.
    JAMA 2019;322:326-335.

  2. Tayal B, Gorcsan J 3rd, Bax JJ, Risum N, et al.
    Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes.
    J Am Coll Cardiol 2018;71:1325-1333.

  3. Moritz S, Gaweda L, Heinz A, Gallinat J, et al.
    Four reasons why early detection centers for psychosis should be renamed and their treatment targets reconsidered: we should not catastrophize a future we can neither reliably predict nor change.
    Psychol Med 2019.

  4. Khan F, Rahman A, Carrier M, Kearon C, et al.
    Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    BMJ 2019;366:l4363.

  5. de Lazzari E, Lonca M, Rojas J, Gonzalez-Cordon A, et al.
    A 24-week pilot study of dual maintenance therapy with raltegravir plus lamivudine.
    AIDS 2019.

  1. Neesgaard B, Pelchen-Matthews A, Ryom L, Florence E, et al.
    Uptake and effectiveness of two-drug compared to three-drug antiretroviral Regimens among HIV-positive Individuals in Europe.
    AIDS 2019.

  2. Truong HM, O'keefe KJ, Pipkin S, Liegler T, et al.
    How are transgender women acquiring hiv? insights from phylogenetic transmission clusters in San Francisco.
    AIDS 2019.

  3. Muss HB, Polley MC, Berry DA, Liu H, et al.
    Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.
    J Clin Oncol 2019.

  4. Stephen ZR, Chiarelli P, Revia RA, Wang K, et al.
    Time-resolved MRI assessment of convection-enhanced delivery by targeted and non-targeted nanoparticles in a human glioblastoma mouse model.
    Cancer Res 2019.

  5. Lindahl LM, Willerslev-Olsen A, Gjerdrum LMR, Nielsen PR, et al.
    Antibiotics inhibit tumor and disease activity in cutaneous T cell lymphoma.
    Blood 2019.


more..

Privacy Policy